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Background: Adult studies have shown a correlation between low socioeconomic status and Type 1 Diabetes
complications, but studies have not been done in children to examine the effect of socioeconomic status on risk
for future complications. This study investigates the relationship between insurance status and parental education
and both glycemic control and cardiovascular disease (CVD) risk factors in youth with type 1 diabetes.
Methods: A cross-sectional study of 295 youth with established type 1 diabetes who underwent examination with
fasting blood draw and reported insurance status and parental education.
Results: Youth with type 1 diabetes and public insurance had higher hemoglobin A1c (HbA1c), body mass index,
hs-CRP, and blood pressure (p < 0.05) than those with private insurance. Insulin regimen varied between insurance
groups, and differences in HbA1c and CVD risk factors, except for diastolic blood pressure (DBP), were no longer
evident after controlling for insulin regimen. Parental education was not associated with HbA1c or CVD risk factors.
Conclusions: Youth with type 1 diabetes and public insurance have worse glycemic control and elevated CVD risk
factors compared to those with private insurance, but this was no longer seen when insulin regimen was
controlled for. Further research is needed to look at differences between those with public insurance and private
insurance that contribute to differences in type 1 diabetes outcomes, and to identify modifiable risk factors in
pediatric patients in order to focus earlier interventions to decrease and prevent future diabetes complications.
Keywords: Type 1 diabetes, Socioeconomic status, Parental education, Hemoglobin A1c, Cardiovascular diseaseBackground
Cardiovascular disease (CVD) is the leading cause of
mortality in patients with diabetes [1]. Vascular changes
are seen in type 1 diabetes during adolescence [2,3] and
lead to premature CVD in adults [4]. Intensive glycemic
control decreases rates of vascular complications [5],
emphasizing the importance of early intensive diabetes
management and modifiable factors that affect glycemic
control and CVD risk.
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unless otherwise stated.[6,7] and mortality [8]. In the pediatric general population,
children whose parents had less than a high school educa-
tion had worse health compared to other children. In the
United States, insurance status reflects one’s socioeco-
nomic status, and those with public or no insurance are
more likely to lack a source of care or get needed medical
care [9]. In children with type 1 diabetes, lower socioeco-
nomic status has been associated with worse glycemic
control [10,11]. Specifically, underinsurance predicted in-
creased incidence of severe hypoglycemia and diabetic
ketoacidosis (DKA) [12,13]. Findings on the effect of pa-
rental education on glycemic control are inconclusive
[14,15]. In studies showing an effect of parental education
on glycemic control, it is often the father’s education level
that is associated with glycemic control [15,16].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Majidi et al. Journal of Diabetes & Metabolic Disorders 2014, 13:59 Page 2 of 4
http://www.jdmdonline.com/content/13/1/59The goal of this study was to explore the association
between parental education and insurance status and
both glycemic control and cardiovascular risk factors.
We hypothesized that those with lower parental educa-
tion level or public insurance would have worse glycemic
control and cardiovascular risk profiles.
Methods
Study design
As part of a prospective cohort study, families of youth
with type 1 diabetes (n = 295) ages 12–19 years and with
diabetes duration >5 years completed questionnaires and
had fasting blood draws at a study visit between 2008 and
2010. This was a convenience sample of consecutive pa-
tients in a large academic pediatric diabetes clinic. Ex-
clusion criteria included a history of abnormal cardiac
anatomy or arrhythmia. This research study was reviewed
and approved by the Colorado Multiple Institutional
Review Board.
Data collection
All families completed the insurance status portion of
the questionnaire, asking whether they had insurance
and if so to list their current insurance carrier. Public in-
surance includes Medicaid and Colorado Access, which
includes Child Health Plan Plus (CHP+). Two hundred
ninety-one subjects completed the parental education
portion of the questionnaire which were listed as 0-20+,
and separated for analysis similarly to SEARCH studies
[17] with both parents’ education levels obtained and
the highest value used for analysis (0–11 years for less
than high school graduate, 12 for high school graduate,
13–15 for some college, and 16-20+ for college graduate
or more). Race/ethnicity was self-reported using the
2000 U.S. Census definitions and categorized as non-
Hispanic white (NHW), Hispanic or Other.
Subjects’ height, weight, and systolic and diastolic
blood pressures (SBP, DBP) were obtained using stan-
dardized methods. Height, weight, and blood pressure
were taken three times and the averages were calculated.
Fasting laboratory measurements included: hemoglobin
A1c (HbA1c), total cholesterol (TC), triglycerides (TG),
HDL-c, calculated LDL-c via the Friedewald equation,
and high sensitivity C-reactive protein (CRP). All mea-
surements were carried out using standard methods in
the University of Colorado Denver Clinical Research
laboratory.
Statistical analysis
Variables were checked for the distributional assumption
of normality. HbA1c, TC, HDL-c, TG, and CRP were
highly skewed; therefore, a natural log transformation was
applied and transformed variables were used in analyses.
ANCOVA with a Tukey-Kramer p-value adjustment wasused to determine the effect of parental education and in-
surance status on glycemic control and cardiovascular risk
factors after adjusting for age, sex, race/ethnicity category,
and insulin regimen (defined as “pump” or “injection”).
Estimates were reported as mean ± standard deviation
(SD) for normally distributed variables and geometric
mean and 95% confidence interval (CI) for non-normally
distributed variables. Chi Square test of independence or
Fisher’s Exact were used to test differences in gender dis-
tribution among categories. ANCOVA p < 0.05 was con-
sidered significant. Adjusted p-values are presented for
pair-wise comparisons. ANCOVA p-values are presented
in Table 1.
Results
Comparison by insurance status showed that children
with private insurance were more likely to be non-
Hispanic white, have lower HbA1c, CRP, SBP, and DBP
(p < 0.05). When insulin regimen was controlled for, only
DBP remained significant (p = 0.01; Table 1). TC, TG,
and LDL-c levels were also lower in children with pri-
vate versus public insurance, but did not reach statistical
significance. Insulin pump therapy was used more often
in those with private insurance, compared to those with
public insurance or no insurance (p = 0.0002).
In contrast, no difference in demographic characteris-
tics (including race/ethnicity), glycemic control, or CVD
risk factors were seen when comparing children with dif-
ferent parental education levels. However, insulin pump
therapy was more likely to be used in those with college
or graduate education (p = 0.0008).
Discussion
This is the first study in children with type 1 diabetes, to
our knowledge, to evaluate the association between
markers of socioeconomic status and cardiovascular risk
factors. This study found a worse profile of CVD risk
factors in children with public versus private insurance,
as well as worse glycemic control, but this association
was no longer seen when insulin regimen was controlled
for, except for diastolic blood pressure. Research in
adults with type 1 diabetes indicates those with lower so-
cioeconomic status have more diabetes complications
[6,7], but this research is lacking in the pediatric popu-
lation. One of the advantages of this study is the eva-
luation of a variety of risk factors for CVD in a pediatric
population before the onset of significant disease. This
allows the opportunity to identify CVD risk factors in
at-risk populations.
This study showed a difference in insulin regimen bet-
ween insurance types, and HbA1c and several cardiovas-
cular disease risk factors were no longer significant after
insulin regimen was controlled for. A recent meta-analysis
looking at differences in HbA1c between children on
Table 1 Participant characteristics by insurance status
No insurance Public insurance Private insurance P-value
(N = 7) (N = 36) (N = 252)
Age (years) 14.6 ± 2.1 14.8 ± 2.2 15.5 ± 2.1 0.18
Sex (% Males) 43% 47% 52% 0.81
Duration of diabetes (years) 8.0 ± 3.0 8.6 ± 3.1 8.8 ± 3.0 0.91
Race/ethnicity (%NHW) 71% 53% 85%** 0.0001
Pumps 1 (16.7%) 11 (30.6%) 153 (61.2%)** 0.0002
BMI (%) 73 ± 27 79 ± 17 68 ± 23 0.07^
HbA1c (%)# 8.7 (7.5–10.1) 9.6 (9.1–10.1) 8.7 (8.5–8.9) 0.10^
HDL-c (mg/dL)# 51 (43–61) 50 (47–54) 50 (49–51) 0.78^
LDL-c (mg/dL)# 77 (60–100) 92 (84–100) 84 (81–87) 0.15^
Total Cholesterol (mg/dL)# 144 (123–168) 163 (153–173) 152 (148–156) 0.16^
Triglycerides (mg/dL)# 66 (52–85) 87 (75–101) 75 (70–79) 0.18^
CRP (mg/L)# 0.55 (0.30–1.02) 0.93 (0.60–1.45) 0.61 (0.52–0.71) 0.09^
SBP (mmHg) 118 ± 11 116 ± 11 113 ± 8 0.11^
DBP (mmHg) 70 ± 8 72 ± 7 68 ± 6** 0.01^
Note: **p < 0.01 for comparison between private insurance and public insurance.
#Geometric mean and 95% confidence interval.
^P-values are for ANCOVA with a Tukey-Kramer p-value adjustment (adjusting for age, sex, race/ethnicity category, and insulin regimen).
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multiple daily injections (MDI) showed no significant dif-
ference, although there was a trend toward better glycemic
control in children on CSII and more data are needed on
this topic [18]. Previous studies show those with a higher
parental education level and those with private insurance
are more likely to be on insulin pump therapy [19]. Within
the institution where this study was conducted, there is no
difference in access to diabetes clinic resources based on
insurance status. Public insurance, such as Medicaid, covers
pump therapy as well as private insurance does, but differ-
ence in pump use persists. For those with public insurance,
other factors may restrict their access to resources and
equal care. This study was not aimed at determining which
factors in those with public or no insurance may affect their
access to care. This is an important further step in research,
to determine what the barriers are to those with public
insurance obtaining access to resources and equal care that
lead to the differences seen in this study.
Another limitation of this study is that certain vari-
ables that may also influence glycemic control and
subsequent CVD status, such as frequency of self-
monitored blood glucose, frequency of clinic visits, and
other markers of patient support, were not investigated
within the scope of this research. Further research is
needed to address how these might be affected by insur-
ance and socioeconomic status, and whether they are in-
dependent markers of subsequent cardiovascular disease.
Such studies could identify variables which may be
amenable to intervention strategies, and also highlight
important disparities in access to health care.Parental education did not have an effect on glycemic
control or CVD risk prolife. Our questionnaire, as in the
SEARCH study [17], did not identify the parent asso-
ciated with each education level, which is a limitation in
our study as analyses could not be done to determine
effect based on paternal or maternal education level.
Previous studies have shown an effect based on paternal,
but not maternal education level [15,16] and not distin-
guishing between these two may have contributed to the
lack of associations in this study.
In summary, this study showed that public insurance
is associated with worse glycemic control and increased
cardiovascular risk factors, but the association no longer
remained after adjusting for insulin regimen. This may
be a marker of financial difficulties in the family. Pa-
tients with public insurance are less likely to receive rou-
tine care [9]. In diabetes, this may translate to missing
clinic appointments, although this has not been specifi-
cally investigated in type 1 diabetes youth with public or
no insurance, including in this study. Parental employ-
ment status was not a component of our questionnaire,
but could be evaluated in further studies to examine po-
tential reasons behind the difference between patients
with public and private insurance that lead to these
discrepancies in outcomes. Further research is needed
to look at discrepancies between those with public insu-
rance and private insurance that may lead to differences
in diabetes outcomes, and to identify modifiable risk
factors in pediatric patients in order to focus earlier
interventions to decrease and prevent future diabetes
complications.
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